Technical Analysis for SYRE - Spyre Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 36.83 | -2.57% | -0.97 |
SYRE closed unchanged on Friday, May 17, 2024, on 77 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | -2.57% | |
NR7 | Range Contraction | -2.57% | |
NR7-2 | Range Contraction | -2.57% | |
Narrow Range Bar | Range Contraction | -2.57% | |
Inside Day | Range Contraction | -2.57% | |
50 DMA Support | Bullish | -2.57% | |
NR7 | Range Contraction | -2.57% | |
Upper Bollinger Band Walk | Strength | -2.57% | |
Inside Day | Range Contraction | -2.57% | |
BB Squeeze Ended | Range Expansion | -2.57% |
Alert | Time |
---|---|
Fell Below 50 DMA | 12 minutes ago |
Fell Below Previous Day's Low | 12 minutes ago |
50 DMA Support | 43 minutes ago |
60 Minute Opening Range Breakdown | 43 minutes ago |
Down 2 % | 43 minutes ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Antibodies Autoimmune Disease Monoclonal Antibody Antibody Inflammatory Bowel Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Antibodies Autoimmune Disease Monoclonal Antibody Antibody Inflammatory Bowel Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 47.97 |
52 Week Low | 2.66 |
Average Volume | 399,179 |
200-Day Moving Average | 22.06 |
50-Day Moving Average | 37.05 |
20-Day Moving Average | 35.24 |
10-Day Moving Average | 36.44 |
Average True Range | 2.80 |
RSI (14) | 55.95 |
ADX | 20.63 |
+DI | 25.61 |
-DI | 13.07 |
Chandelier Exit (Long, 3 ATRs) | 32.10 |
Chandelier Exit (Short, 3 ATRs) | 39.66 |
Upper Bollinger Bands | 39.11 |
Lower Bollinger Band | 31.37 |
Percent B (%b) | 0.83 |
BandWidth | 21.95 |
MACD Line | 0.64 |
MACD Signal Line | 0.22 |
MACD Histogram | 0.4148 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 39.66 | ||||
Resistance 3 (R3) | 39.58 | 38.88 | 39.35 | ||
Resistance 2 (R2) | 38.88 | 38.41 | 38.92 | 39.25 | |
Resistance 1 (R1) | 38.34 | 38.11 | 37.99 | 38.42 | 39.14 |
Pivot Point | 37.64 | 37.64 | 37.47 | 37.68 | 37.64 |
Support 1 (S1) | 37.10 | 37.17 | 36.75 | 37.18 | 36.46 |
Support 2 (S2) | 36.40 | 36.87 | 36.44 | 36.35 | |
Support 3 (S3) | 35.86 | 36.40 | 36.25 | ||
Support 4 (S4) | 35.94 |